GENETIC LINKAGE STUDY OF SCHIZOPHRENIA
精神分裂症的遗传连锁研究
基本信息
- 批准号:6469979
- 负责人:
- 金额:$ 2.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:Chinese clinical research diagnosis quality /standard family genetics gene expression genetic disorder genetic susceptibility genotype human genetic material tag human population genetics human subject human tissue interview linkage mapping mental disorder diagnosis schizophrenia tissue resource /registry
项目摘要
It is proposed to study 90 sib-pairs with the disorder. Specific aims
are: (1) to clinically assess a pedigree sample having adequate power
to detect genes for schizophrenia; (2) to conduct a genome scan to find
such loci; and (3) to transmit all data to the NIMH designated cell
repository and data management centers. The goals will be attained by
achieving the following: (1) from Taiwan and China, 900 Han Chinese sib-
pairs having DSM-IV schizophrenia will be collected. (2) The
investigators will examine all family members using the Diagnostic
Interview for Genetic Studies and the Family Interview for Genetic
Studies. The PI participated in the development and field testing of
these interviews and has an already established training program for
their use. They have been translated into Mandarin by the Taiwanese
investigators, who have used them in prior studies. (3) Blood samples
will be sent to the NIMH designated cell repository for creation of
lymphoblastoid cell lines. (4) Clinical data will be entered using the
database software created for the NIMH Human Genetics Initiative. Data
will be vetted and sent to the NIMH designated data management center.
(5) The investigators will complete a genome scan using 450 markers
spaced at an average of 10 cM intervals using markers that have been
optimized for use in the Han Chinese population. The scan will be
completed with no cost to the NIMH through an agreement with Millenium
Pharmaceuticals, a biotechnology company in the Boston area that the PI
has worked with on a prior genetic linkage study of schizophrenia. All
genetic analyses will be approved by the consultant, Eric Lander, Ph.D.
(6) all clinical data will be made available to the scientific community
by the end of the funding period. All genotypes will be available on
year after they are created but no later than a year after the funding
period. This project is feasible because: (1) The PI has already
coordinated one multi-site genetic linkage study of schizophrenia and
has participated in a second. (2) The investigators have a longstanding
relationship with the Taiwanese collaborators and an effective, albeit,
more recent working relationship with the Chinese collaborator. (3) The
investigators have conservatively estimated that each site has access
to more than enough available families having two schizophrenic
siblings. (4) The PI's Harvard team has had prior experience
collaborating on genotyping and linkage analysis projects with
Millennium Pharmaceuticals. This, and Millennium's prior genotyping
experience shows that the genotyping phase of the work is feasible.
建议研究90个同胞对的障碍。 具体目标
是:(1)临床评估具有足够功效的谱系样本
检测精神分裂症的基因;(2)进行基因组扫描,
(3)将所有数据传输到NIMH指定的小区
存储库和数据管理中心。这些目标将通过以下方式实现:
实现以下目标:(1)从台湾和中国,900汉族同胞-
将收集患有DSM-IV精神分裂症的配对。(2)的
调查人员将使用诊断工具检查所有家庭成员。
遗传学研究访谈和遗传学家庭访谈
问题研究主要研究者参与了
这些面试,并有一个已经建立的培训计划,
他们的使用。 他们已经被台湾人翻译成普通话
研究人员在之前的研究中使用过它们。(3)血样
将被发送到NIMH指定的细胞库,
淋巴母细胞样细胞系。(4)临床数据将使用
为NIMH人类遗传学倡议创建的数据库软件。 数据
将被审查并发送到NIMH指定的数据管理中心。
(5)研究人员将使用450个标记完成基因组扫描
以平均10 cM的间隔,使用已经被
优化用于中国汉族人群。 扫描将是
通过与Millenium的协议,NIMH无需支付任何费用即可完成
制药公司,波士顿地区的一家生物技术公司,PI
曾参与过精神分裂症的遗传连锁研究 所有
遗传分析将由顾问Eric Lander博士批准。
(6)所有的临床数据将提供给科学界
在融资期结束时。 所有基因型将在
一年后,他们被创建,但不迟于一年后,资金
期 该项目是可行的,因为:(1)PI已经
协调一项精神分裂症多位点遗传连锁研究,
参加了第二次。(2)调查人员长期以来
与台湾合作者的关系,以及一个有效的,尽管,
最近与中国合作伙伴建立了合作关系。(3)的
研究人员保守估计,每个站点都可以访问
有两个精神分裂症患者的家庭
兄妹(4)PI的哈佛团队有过
在基因分型和连锁分析项目上与
千禧制药 这个加上千禧年之前的基因分型
经验表明,基因分型阶段的工作是可行的。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Association of older paternal age with earlier onset among co-affected schizophrenia sib-pairs.
在共同患病的精神分裂症同胞对中,父亲年龄较大与发病较早之间存在关联。
- DOI:10.1017/s0033291715000203
- 发表时间:2015
- 期刊:
- 影响因子:6.9
- 作者:Wang,SH;Liu,CM;Hwu,HG;Hsiao,CK;Chen,WJ
- 通讯作者:Chen,WJ
Further evidence for an association of G72/G30 with schizophrenia in Chinese.
G72/G30 与中国人精神分裂症相关的进一步证据。
- DOI:10.1016/j.schres.2008.07.016
- 发表时间:2009
- 期刊:
- 影响因子:4.5
- 作者:Shi,Jiajun;Badner,JudithA;Gershon,ElliotS;Chunyu,Liu;Willour,VirginiaL;Potash,JamesB
- 通讯作者:Potash,JamesB
Handedness and schizotypy in non-psychotic relatives of patients with schizophrenia.
- DOI:10.1080/1357650x.2010.511646
- 发表时间:2011-11
- 期刊:
- 影响因子:1.4
- 作者:Tsuang HC;Liu CM;Hwang TJ;Hsieh MH;Faraone SV;Tsuang MT;Hwu HG;Chen WJ
- 通讯作者:Chen WJ
Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits.
- DOI:10.1371/journal.pone.0150435
- 发表时间:2016
- 期刊:
- 影响因子:3.7
- 作者:Liu YL;Wang SC;Hwu HG;Fann CS;Yang UC;Yang WC;Hsu PC;Chang CC;Wen CC;Tsai-Wu JJ;Hwang TJ;Hsieh MH;Liu CC;Chien YL;Fang CP;Faraone SV;Tsuang MT;Chen WJ;Liu CM
- 通讯作者:Liu CM
The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population.
DAO 基因与精神分裂症相关,并与台湾汉族人群中的其他基因相互作用。
- DOI:10.1371/journal.pone.0060099
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:Yang,Hsin-Chou;Liu,Chih-Min;Liu,Yu-Li;Chen,Chia-Wei;Chang,ChienChing;Fann,CathySJ;Chiou,Jen-Jie;Yang,Ueng-Cheng;Chen,Chun-Houh;Faraone,StephenV;Tsuang,MingT;Hwu,Hai-Gwo
- 通讯作者:Hwu,Hai-Gwo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MING T. TSUANG其他文献
MING T. TSUANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MING T. TSUANG', 18)}}的其他基金
Biomarkers for Marine PTSD Risk and Resilience
海洋创伤后应激障碍风险和恢复力的生物标志物
- 批准号:
7891279 - 财政年份:2009
- 资助金额:
$ 2.86万 - 项目类别:
Biomarkers for Marine PTSD Risk and Resilience
海洋创伤后应激障碍风险和恢复力的生物标志物
- 批准号:
7739918 - 财政年份:2009
- 资助金额:
$ 2.86万 - 项目类别:
Genetic Predictors of Neuropsychological and Functional Outcomes in Schizophrenia
精神分裂症神经心理和功能结果的遗传预测因素
- 批准号:
7673298 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
1/2 Expanding Rapid Ascertainment Networks Of Schizophrenia Families In Taiwan
1/2 扩大台湾精神分裂症家族快速查明网络
- 批准号:
7694367 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
Genetic Predictors of Neuropsychological and Functional Outcomes in Schizophrenia
精神分裂症神经心理和功能结果的遗传预测因子
- 批准号:
7885350 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
1/2 Expanding Rapid Ascertainment Networks Of Schizophrenia Families In Taiwan
1/2 扩大台湾精神分裂症家族快速查明网络
- 批准号:
8303447 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
Genetic Predictors of Neuropsychological and Functional Outcomes in Schizophrenia
精神分裂症神经心理和功能结果的遗传预测因素
- 批准号:
8115826 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
1/2 Expanding Rapid Ascertainment Networks Of Schizophrenia Families In Taiwan
1/2 扩大台湾精神分裂症家族快速查明网络
- 批准号:
8075454 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
Genetic Predictors of Neuropsychological and Functional Outcomes in Schizophrenia
精神分裂症神经心理和功能结果的遗传预测因子
- 批准号:
8301790 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
1/2 Expanding Rapid Ascertainment Networks Of Schizophrenia Families In Taiwan
1/2 扩大台湾精神分裂症家族快速查明网络
- 批准号:
7920227 - 财政年份:2008
- 资助金额:
$ 2.86万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 2.86万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 2.86万 - 项目类别:














{{item.name}}会员




